GPR4
G-prodeshotein coupled receptor 4
Also known as: GPR4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P46093
- Gene
- GPR4
- Ensembl
- ENSG00000177464
- Chromosome
- 19
- Canonical length
- 362 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins
OverviewNCBI Gene
Enables G protein-coupled receptor activity. Involved in several processes, including G protein-coupled receptor signaling pathway; positive regulation of Rho protein signal transduction; and response to acidic pH. Located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
362 residues, UniProt reviewed canonical sequence.
>P46093|GPR4
1 MGNHTWEGCH VDSRVDHLFP PSLYIFVIGV GLPTNCLALW AAYRQVQQRN ELGVYLMNLS
61 IADLLYICTL PLWVDYFLHH DNWIHGPGSC KLFGFIFYTN IYISIAFLCC ISVDRYLAVA
121 HPLRFARLRR VKTAVAVSSV VWATELGANS APLFHDELFR DRYNHTFCFE KFPMEGWVAW
181 MNLYRVFVGF LFPWALMLLS YRGILRAVRG SVSTERQEKA KIKRLALSLI AIVLVCFAPY
241 HVLLLSRSAI YLGRPWDCGF EERVFSAYHS SLAFTSLNCV ADPILYCLVN EGARSDVAKA
301 LHNLLRFLAS DKPQEMANAS LTLETPLTSK RNSTAKAMTG SWAATPPSQG DQVQLKMLPP
361 AQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GPR4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 38 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 38 nTPM
- lung: 27 nTPM
- heart muscle: 23 nTPM
- breast: 22 nTPM
- kidney: 21 nTPM
- thyroid gland: 18 nTPM
Single-cell type
- pericytes: 0.3 nCPM
- lymphatic endothelial cells: 0.2 nCPM
- vascular endothelial cells: 0.2 nCPM
- vascular smooth muscle cells: 0.2 nCPM
- adipocytes: 0 nCPM
- adrenal cortex cells: 0 nCPM
Immune cell
- naive B-cell: 0.1 nTPM
- neutrophil: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- thalamus: 19 nTPM
- pons: 14 nTPM
- medulla oblongata: 13 nTPM
- midbrain: 13 nTPM
- cerebral cortex: 12 nTPM
- amygdala: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.86
- gnomAD pLI
- 0.1
- gnomAD missense Z
- 2.53
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-activating G protein-coupled receptor signaling pathway
- angiogenesis involved in wound healing
- cellular response to acidic pH
- G protein-coupled receptor signaling pathway
- glomerular mesangial cell development
- negative regulation of angiogenesis
- phospholipase C-activating G protein-coupled receptor signaling pathway
- positive regulation of inflammatory response
- positive regulation of Rho protein signal transduction
- regulation of cell adhesion
- regulation of vascular permeability
- response to acidic pH
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- G protein-coupled receptor, rhodopsin-like
- GPCR, rhodopsin-like, 7TM
- 7 transmembrane receptor (rhodopsin family)
- G protein-coupled receptor 4 orphan
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GPR4 as an antibody target. Whether an autoantibody or antibody against GPR4 could matter depends on whether native GPR4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GPR4 is annotated at the cell surface, where native GPR4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GPR4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...